Similar Papers

Paper Title
Journal
Date
Author
Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
Kim Papp ... Eric L Simpson
Journal of the American Academy of Dermatology | VOL. 85
Kim Papp, et. al.Kim Papp ... Eric L Simpson
04 May 2021
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis
Joyce M.C Teng ... Leslie Castelo-Soccio
Journal of the American Academy of Dermatology | VOL. 87
Joyce M.C Teng, et. al.Joyce M.C Teng ... Leslie Castelo-Soccio
21 Jul 2022
A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque Psoriasis.
Burhan Engin ... Server Serdaroğlu
Dermatology and therapy | VOL. 14
Burhan Engin, et. al.Burhan Engin ... Server Serdaroğlu
01 Dec 2024
A Randomized, Parallel Group, Open Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with Clobetasol Propionate Cream (Impoyz™), 0.025% versus Clobetasol Propionate (Temovate®)
Zoe Diana Draelos ... Raymond Cornelison
SKIN The Journal of Cutaneous Medicine | VOL. 2
Zoe Diana Draelos, et. al.Zoe Diana Draelos ... Raymond Cornelison
09 Nov 2018
View more papers

More From: Clinical therapeutics

Paper Title
Journal
Date
Author
PHEMI-Phenylbutyrate in Patients With Lactic Acidosis: A Pilot, Single Arm, Phase I/II, Open-Label Trial.
Silvia Marchet ... Costanza Lamperti
Clinical therapeutics | VOL. 47
Silvia Marchet, et. al.Silvia Marchet ... Costanza Lamperti
01 May 2025
Individual, Social and Environmental Factors Influencing Medication-Taking Among Adults of Vietnamese Heritage With Type 2 Diabetes Living in Australia: A Qualitative Study.
Olumuyiwa Omonaiye ... Elizabeth Manias
Clinical therapeutics | VOL. 47
Olumuyiwa Omonaiye, et. al.Olumuyiwa Omonaiye ... Elizabeth Manias
01 May 2025
Editorial Board
-
Clinical Therapeutics | VOL. 47
--
01 May 2025
Words Matter: An Attack on Evidence-Based, Peer-Reviewed Science.
Jill L Maron
Clinical therapeutics | VOL. 47
Jill L MaronJill L Maron
01 May 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.